CY2021027I1 - Σκευασματα αντισωματων anti-cd20 - Google Patents

Σκευασματα αντισωματων anti-cd20

Info

Publication number
CY2021027I1
CY2021027I1 CY2021027C CY2021027C CY2021027I1 CY 2021027 I1 CY2021027 I1 CY 2021027I1 CY 2021027 C CY2021027 C CY 2021027C CY 2021027 C CY2021027 C CY 2021027C CY 2021027 I1 CY2021027 I1 CY 2021027I1
Authority
CY
Cyprus
Prior art keywords
antibody preparation
antibody
preparation
Prior art date
Application number
CY2021027C
Other languages
English (en)
Other versions
CY2021027I2 (el
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority to CY2021027C priority Critical patent/CY2021027I1/el
Publication of CY2021027I2 publication Critical patent/CY2021027I2/el
Publication of CY2021027I1 publication Critical patent/CY2021027I1/el

Links

CY2021027C 2021-09-14 2021-09-14 Σκευασματα αντισωματων anti-cd20 CY2021027I1 (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CY2021027C CY2021027I1 (el) 2021-09-14 2021-09-14 Σκευασματα αντισωματων anti-cd20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CY2021027C CY2021027I1 (el) 2021-09-14 2021-09-14 Σκευασματα αντισωματων anti-cd20

Publications (2)

Publication Number Publication Date
CY2021027I2 CY2021027I2 (el) 2021-12-31
CY2021027I1 true CY2021027I1 (el) 2021-12-31

Family

ID=88102294

Family Applications (1)

Application Number Title Priority Date Filing Date
CY2021027C CY2021027I1 (el) 2021-09-14 2021-09-14 Σκευασματα αντισωματων anti-cd20

Country Status (1)

Country Link
CY (1) CY2021027I1 (el)

Also Published As

Publication number Publication date
CY2021027I2 (el) 2021-12-31

Similar Documents

Publication Publication Date Title
MA53434A (fr) Anticorps anti-tigit
MA52884A (fr) Anticorps anti-il-11
MA47694A (fr) Anticorps anti-tigit
MA49034A (fr) Anticorps anti-lag3
DK3544636T3 (da) Pyrrolobenzodiazepin-antistof-konjugater
DK3408295T3 (da) Farmaceutisk sammensætning, som omfatter bispecifikke antistofkonstruktioner
DK3411404T3 (da) Psma- og cd3-bispecifikke t-celleinddragende antistofkonstruktioner
MA52212A (fr) Anticorps multivalent
DK3606961T3 (da) Garp-tgf-beta-antistoffer
MA52366A (fr) Anticorps anti-tl1a optimisés
MA52152A (fr) Anticorps
DK3475303T3 (da) Anti-cd19-antistofformuleringer
MA51134A (fr) Anticorps anti-alpha-synucléine
MA49250A (fr) Nouveaux anticorps anti-cd3
DK3416984T3 (da) Kimært hunde-anti-cd20-antistof
MA51135A (fr) Anticorps anti-alpha-synucléine
MA56466A (fr) Anticorps anti-epha4
MA50654A (fr) Anticorps anti-pacap
MA55600A (fr) Anticorps anti-ige
MA49257A (fr) Anticorps anti-trkb
CY2021027I2 (el) Σκευασματα αντισωματων anti-cd20
MA56394A (fr) Anticorps anti-angpt2
MA55519A (fr) Anticorps anti-fgf23
DK3996688T3 (da) Farmaceutisk præparat
UA41578S (uk) Ложка столова